(THO) Thor Industries - Ratings and Ratios
Travel Trailer, Motorhome, Fifth Wheel, Campervan, Component
Dividends
| Dividend Yield | 1.97% |
| Yield on Cost 5y | 2.41% |
| Yield CAGR 5y | -2.57% |
| Payout Consistency | 91.1% |
| Payout Ratio | 38.2% |
| Risk via 10d forecast | |
|---|---|
| Volatility | 36.8% |
| Value at Risk 5%th | 55.6% |
| Relative Tail Risk | -8.10% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | 0.09 |
| Alpha | -16.45 |
| CAGR/Max DD | 0.22 |
| Character TTM | |
|---|---|
| Hurst Exponent | 0.449 |
| Beta | 1.034 |
| Beta Downside | 1.015 |
| Drawdowns 3y | |
|---|---|
| Max DD | 48.40% |
| Mean DD | 17.77% |
| Median DD | 18.14% |
Description: THO Thor Industries November 07, 2025
Thor Industries (NYSE: THO) designs, manufactures and sells a full line of recreational vehicles-including travel trailers, Class A/B/C motorhomes, fifth-wheels, camper-vans and related accessories-through an extensive network of independent dealers across the United States, Europe and Canada.
Key operating metrics from the most recent fiscal year show revenue of roughly $6.1 billion, an operating margin near 7 percent, and an inventory turnover of about 45 days, reflecting the company’s ability to manage supply-chain pressures while maintaining a broad product mix.
Demand for RVs remains highly sensitive to discretionary-spending trends, consumer confidence, and financing conditions; recent data indicate that a 1-percentage-point rise in the 30-year mortgage rate historically depresses RV sales by roughly 3-4 percent, while a strong housing market and low-interest auto loans tend to boost orders.
Sector-wide, the RV industry is being driven by a “stay-cation” shift and the growth of remote-work lifestyles, which have expanded the addressable market beyond traditional vacationers and are supporting a multi-year growth outlook of 5-6 percent CAGR for total shipments.
For a deeper quantitative breakdown of THO’s valuation metrics and scenario analysis, the ValueRay platform offers a useful toolkit.
Piotroski VR‑10 (Strict, 0-10) 4.5
| Net Income (282.1m TTM) > 0 and > 6% of Revenue (6% = 589.5m TTM) |
| FCFTA 0.05 (>2.0%) and ΔFCFTA -0.34pp (YES ≥ +1.0pp, WARN ≥ +0.5pp) |
| NWC/Revenue 12.36% (prev 10.86%; Δ 1.51pp) (YES ≤20% & Δ≤-1pp; WARN ≤25% & Δ≤0 oder ≤40% & Δ≤-3pp) |
| CFO/TA 0.07 (>3.0%) and CFO 502.3m > Net Income 282.1m (YES >=105%, WARN >=100%) |
| Net Debt (-507.0m) to EBITDA (601.1m) ratio: -0.84 <= 3.0 (WARN <= 3.5) |
| Current Ratio 1.81 (target 1.5–3.0; WARN 1.2–<1.5 or >3.0–5.0; CFO/TA gate active) |
| Outstanding Shares last Quarter (53.0m) change vs 12m ago 0.00% (target <= -2.0% for YES) |
| Gross Margin 14.05% (prev 15.09%; Δ -1.05pp) >=18% & Δ>=+0.5pp (WARN >=15% & Δ>=0) |
| Asset Turnover 141.7% (prev 140.9%; Δ 0.82pp) >=50% & Δ>=+2pp (WARN >=35% & Δ>=0) |
| Interest Coverage Ratio 7.83 (EBITDA TTM 601.1m / Interest Expense TTM 42.2m) >= 6 (WARN >= 3) |
Altman Z'' 7.44
| (A) 0.17 = (Total Current Assets 2.72b - Total Current Liabilities 1.51b) / Total Assets 6.99b |
| (B) 0.63 = Retained Earnings (Balance) 4.40b / Total Assets 6.99b |
| (C) 0.05 = EBIT TTM 330.6m / Avg Total Assets 6.93b |
| (D) 3.74 = Book Value of Equity 4.44b / Total Liabilities 1.19b |
| Total Rating: 7.44 = (6.56 * A) + (3.26 * B) + (6.72 * C) + (1.05 * D) |
ValueRay F-Score (Strict, 0-100) 44.98
| 1. Piotroski 4.50pt |
| 2. FCF Yield 7.60% |
| 3. FCF Margin 3.80% |
| 4. Debt/Equity 0.00 |
| 5. Debt/Ebitda -0.84 |
| 6. ROIC - WACC (= -5.26)% |
| 7. RoE 6.73% |
| 8. Rev. Trend -71.41% |
| 9. EPS Trend -58.02% |
What is the price of THO shares?
Over the past week, the price has changed by +1.61%, over one month by +1.04%, over three months by -1.96% and over the past year by -0.29%.
Is THO a buy, sell or hold?
- Strong Buy: 2
- Buy: 2
- Hold: 10
- Sell: 2
- Strong Sell: 1
What are the forecasts/targets for the THO price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 108.6 | 6% |
| Analysts Target Price | 108.6 | 6% |
| ValueRay Target Price | 104.5 | 2% |
THO Fundamental Data Overview December 13, 2025
P/E Trailing = 19.7038
P/E Forward = 25.974
P/S = 0.551
P/B = 1.2777
P/EG = 1.1129
Beta = 1.317
Revenue TTM = 9.83b USD
EBIT TTM = 330.6m USD
EBITDA TTM = 601.1m USD
Long Term Debt = 913.1m USD (from longTermDebt, last quarter)
Short Term Debt = 2.83m USD (from shortTermDebt, last quarter)
Debt = 2.83m USD (from shortLongTermDebtTotal, last quarter)
Net Debt = -507.0m USD (from netDebt column, last quarter)
Enterprise Value = 4.91b USD (5.41b + Debt 2.83m - CCE 509.9m)
Interest Coverage Ratio = 7.83 (Ebit TTM 330.6m / Interest Expense TTM 42.2m)
FCF Yield = 7.60% (FCF TTM 373.0m / Enterprise Value 4.91b)
FCF Margin = 3.80% (FCF TTM 373.0m / Revenue TTM 9.83b)
Net Margin = 2.87% (Net Income TTM 282.1m / Revenue TTM 9.83b)
Gross Margin = 14.05% ((Revenue TTM 9.83b - Cost of Revenue TTM 8.45b) / Revenue TTM)
Gross Margin QoQ = 13.43% (prev 14.70%)
Tobins Q-Ratio = 0.70 (Enterprise Value 4.91b / Total Assets 6.99b)
Interest Expense / Debt = 317.7% (Interest Expense 8.99m / Debt 2.83m)
Taxrate = 28.68% (9.32m / 32.5m)
NOPAT = 235.8m (EBIT 330.6m * (1 - 28.68%))
Current Ratio = 1.81 (Total Current Assets 2.72b / Total Current Liabilities 1.51b)
Debt / Equity = 0.00 (Debt 2.83m / totalStockholderEquity, last quarter 4.30b)
Debt / EBITDA = -0.84 (Net Debt -507.0m / EBITDA 601.1m)
Debt / FCF = -1.36 (Net Debt -507.0m / FCF TTM 373.0m)
Total Stockholder Equity = 4.19b (last 4 quarters mean from totalStockholderEquity)
RoA = 4.03% (Net Income 282.1m / Total Assets 6.99b)
RoE = 6.73% (Net Income TTM 282.1m / Total Stockholder Equity 4.19b)
RoCE = 6.48% (EBIT 330.6m / Capital Employed (Equity 4.19b + L.T.Debt 913.1m))
RoIC = 4.57% (NOPAT 235.8m / Invested Capital 5.16b)
WACC = 9.82% (E(5.41b)/V(5.42b) * Re(9.83%) + (debt cost/tax rate unavailable))
Discount Rate = 9.83% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: -33.33 | Cagr: -0.82%
[DCF Debug] Terminal Value 71.05% ; FCFE base≈379.8m ; Y1≈360.0m ; Y5≈343.3m
Fair Price DCF = 86.29 (DCF Value 4.56b / Shares Outstanding 52.8m; 5y FCF grow -6.76% → 3.0% )
EPS Correlation: -58.02 | EPS CAGR: -48.08% | SUE: 0.85 | # QB: 2
Revenue Correlation: -71.41 | Revenue CAGR: -12.10% | SUE: 2.69 | # QB: 3
EPS next Quarter (2026-01-31): EPS=0.03 | Chg30d=-0.029 | Revisions Net=-3 | Analysts=13
EPS current Year (2026-07-31): EPS=4.24 | Chg30d=+0.165 | Revisions Net=+8 | Growth EPS=-12.5% | Growth Revenue=+0.5%
EPS next Year (2027-07-31): EPS=5.68 | Chg30d=+0.006 | Revisions Net=+3 | Growth EPS=+34.1% | Growth Revenue=+5.2%
Additional Sources for THO Stock
Tweets: X | Stocktwits
Fund Manager Positions: Dataroma | Stockcircle